Search Results
Eli Lilly CEO David Ricks on positive Alzheimer's drug trial data
Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results
Eli Lilly CEO discusses FDA's approval of Biogen's new Alzheimer's drug
Eli Lilly CEO on slashing insulin prices, approval timelines for weight-loss and Alzheimer's drugs
Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug
Eli Lilly CEO discusses COVID-19 treatments, and Biogen's FDA approval of new Alzheimer's drug
Clinical trial results released for potential new Alzheimer's drug
Eli Lilly CEO David Ricks breaks down second-quarter earnings and drug pipeline
Eli Lilly’s CEO David Ricks delves into the drivers of the healthcare industry
Eli Lilly testing Alzheimer's drug
Eli Lilly CEO David Ricks on the end of antibody study in hospitalized patients
Facing Forward: Eli Lilly CEO David Ricks on COVID-19 treatments
